Antimicrobial activities of rifalazil, clarithromycin, and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium cultivated in 7HSF medium

Japanese Journal of Chemotherapy

Volumn 49, Issue 11, 2001, Pages 649-652

  Sano, K ^a   Sato, K ^a   Tomioka, H ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Clarithromycin; Levofloxacin; Mycobacterium avium; Rifalazil

Indexed keywords

CLARITHROMYCIN; LEVOFLOXACIN; RIFALAZIL;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; COLONY FORMING UNIT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; TEMPERATURE;

EID: 0035214612     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Prospects for development of new antimicrobial drugs, with special reference to a new benzoxazinorifamycin, KRM-1648
2. In vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis
3. In vitro antimycobacterial activity of newly synthesized benzoxazinorifamycins
4. Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in mice
5. Durable cure for tuberculosis: Rifalazil in combination with isoniazid in a murine model of Mycobacterium tuberculosis
6. Safety and bactericidal activity of rifalazil in patients with pulmonary tuberculosis
7. In vitro activity of the benzoxazinorifamycin KRM-1648 against drug-susceptible and multidrug-resistant tubercle bacilli
8. Activities of the benzoxazinorifamycin KRM-1648 and ethambutol against Mycobacterium avium complex in vitro and in macrophages
9. Antimicrobial activities of benzoxazinorifamycin KRM-1648, clarithromycin, and levofloxacin against intracellular Mycobacterium avium complex phagocytosed by murine peritoneal macrophages
10. Antimicrobial activities of benzoxazinorifamycin (KRM-1648) and clarithromycin against Mycobacterium avium-intracellulare complex within murine peritoneal macrophages, human macrophage-like cells and human alveolar epithelial cells
11. Antimicrobial activities of levofloxacin, clarithromycin, and KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium complex replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines
12. Clinical trials in Mycobacterium avium therapy: Lessons to take home
13. Clarithromycin against Mycobacterium avium complex infection
14. Therapeutic effect of KRM-1648 with various antimicrobials against Mycobacterium avium complex infection in mice
15. Effects of benzoxazinorifamycin KRM-1648 on cytokine production at sites of Mycobacterium avium complex infection induced in mice